Implantable cardioverter-defibrillators in patients with CF-LVAD does not provide mortality benefit


eMediNexus    02 December 2017

It is known that implantable cardioverter defibrillators ICDs provide a significant mortality benefit for appropriately selected patients with advanced heart failure. The mortality benefit has been shown in patients with a pulsatile left ventricular assist device LVAD however it remains unclear whether patients with a continuous flow LVAD CF LVAD derive the same benefit. Thus the investigators performed a study to determine if the presence of an ICD provided a mortality benefit during CF LVAD support as a bridge to transplantation. The results published in the Journal of Heart and Lung Transplantation showed no difference in survival during device support between patients with and without an ICD. Thus it was concluded that ICD does not provide mortality benefit in patients bridged to transplantation with a CF LVAD.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.